BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11274785)

  • 1. Parafascicular thalamic nucleus deafferentation reduces c-fos expression induced by dopamine D-1 receptor stimulation in rat striatum.
    Giorgi S; Rimoldi M; Consolo S
    Neuroscience; 2001; 103(3):653-61. PubMed ID: 11274785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The parafascicular thalamic nucleus modulates messenger RNA encoding glutamate decarboxylase 67 in rat striatum.
    Giorgi S; Rimoldi M; Rossi A; Consolo S
    Neuroscience; 1997 Oct; 80(3):793-801. PubMed ID: 9276494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the parafascicular thalamic nucleus and N-methyl-D-aspartate transmission in the D1-dependent control of in vivo acetylcholine release in rat striatum.
    Consolo S; Baronio P; Guidi G; Di Chiara G
    Neuroscience; 1996 Mar; 71(1):157-65. PubMed ID: 8834399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine augments c-fos and zip/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum.
    Wang JQ; McGinty JF
    Neuroscience; 1996 Jun; 72(3):601-16. PubMed ID: 8861055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.
    Le Moine C; Svenningsson P; Fredholm BB; Bloch B
    J Neurosci; 1997 Oct; 17(20):8038-48. PubMed ID: 9315922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour.
    Ferré S; Rimondini R; Popoli P; Reggio R; Pèzzola A; Hansson AC; Andersson A; Fuxe K
    Eur J Neurosci; 1999 Nov; 11(11):3884-92. PubMed ID: 10583477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in CArG-binding protein A expression levels following injection(s) of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat.
    Rushlow WJ; Rajakumar B; Flumerfelt BA; Naus CC; Rajakumar N
    Neuroscience; 2000; 98(1):69-78. PubMed ID: 10858613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-fos gene expression is induced in a subpopulation of striatal neurons following a single administration of a dopamine D1-receptor agonist in adult rats lesioned with 6-OHDA as neonates.
    Soghomonian JJ; Laprade N; Sandstrom M; Bruno JP
    Brain Res Mol Brain Res; 1998 Jun; 57(1):155-60. PubMed ID: 9630593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates.
    Sandstrom MI; Sarter M; Bruno JP
    Brain Res Dev Brain Res; 1996 Oct; 96(1-2):148-58. PubMed ID: 8922677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors.
    Keefe KA; Gerfen CR
    J Comp Neurol; 1996 Apr; 367(2):165-76. PubMed ID: 8708002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons.
    Svenningsson P; Fredholm BB; Bloch B; Le Moine C
    Neuroscience; 2000; 98(4):749-57. PubMed ID: 10891618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum.
    Berretta S; Robertson HA; Graybiel AM
    J Neurophysiol; 1992 Sep; 68(3):767-77. PubMed ID: 1359024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors.
    Morelli M; Cozzolino A; Pinna A; Fenu S; Carta A; Di Chiara G
    Brain Res; 1993 Oct; 623(2):334-6. PubMed ID: 8221117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum.
    Nakazato E; Ohno M; Watanabe S
    Eur J Pharmacol; 1998 Jan; 342(2-3):209-12. PubMed ID: 9548387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.